GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $4.72 $7.24 Monday, 22nd Apr 2024 AFMD stock ended at $5.00. This is 2.91% less than the trading day before Friday, 19th Apr 2024. During the day the stock fluctuated 11.23% from a day low at $4.72 to a day high of $5.25.
90 days $4.25 $7.24
52 weeks $2.24 $11.10

Historical Affimed N.V. prices

Date Open High Low Close Volume
Jan 03, 2024 $6.35 $6.48 $5.63 $5.88 114 107
Jan 02, 2024 $6.79 $7.40 $6.25 $6.25 226 656
Dec 29, 2023 $5.34 $6.28 $5.30 $6.25 204 287
Dec 28, 2023 $4.70 $5.40 $4.70 $5.39 161 331
Dec 27, 2023 $4.60 $4.80 $4.42 $4.72 157 708
Dec 26, 2023 $4.70 $4.70 $4.41 $4.56 149 624
Dec 22, 2023 $4.72 $4.80 $4.30 $4.47 86 112
Dec 21, 2023 $3.70 $4.77 $3.60 $4.55 262 277
Dec 20, 2023 $3.78 $4.00 $3.71 $3.78 97 328
Dec 19, 2023 $4.13 $4.14 $3.72 $4.00 99 923
Dec 18, 2023 $4.00 $4.19 $3.94 $4.00 134 865
Dec 15, 2023 $4.10 $4.13 $3.85 $3.87 300 611
Dec 14, 2023 $4.10 $4.10 $3.84 $4.02 105 919
Dec 13, 2023 $3.55 $4.10 $3.55 $4.08 335 420
Dec 12, 2023 $3.60 $3.81 $3.32 $3.49 194 207
Dec 11, 2023 $4.25 $4.30 $3.60 $3.69 538 455
Dec 08, 2023 $4.15 $4.25 $3.65 $4.20 162 308
Dec 07, 2023 $4.43 $4.43 $3.82 $4.00 127 094
Dec 06, 2023 $4.40 $4.70 $4.11 $4.29 101 620
Dec 05, 2023 $4.40 $4.55 $4.38 $4.41 47 924
Dec 04, 2023 $4.74 $4.74 $4.40 $4.54 37 242
Dec 01, 2023 $4.45 $4.51 $4.22 $4.50 33 166
Nov 30, 2023 $5.34 $5.34 $4.40 $4.50 84 294
Nov 29, 2023 $5.32 $5.50 $5.20 $5.20 65 497
Nov 28, 2023 $4.30 $5.24 $4.21 $5.24 92 716
Click to get the best stock tips daily for free!

About Affimed N.V.

Affimed N.V. Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in Phase I clinical trial for hodgkin lymphoma. The company is also developing AFM24, a tetravalent, bispec... AFMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT